Cardiovascular Health — Race & Medicine

In development…

Carlos Rodriguez, MD, MPH presents on Cardiovascular Disease - Health Disparities in Underrepresented Minorities. He is recognized as a national leader in the study of cardiovascular risk factors that affect minorities, his research focus includes hypertensive heart disease, heart failure, bio-behavioral cardiovascular health, cardiovascular epidemiology and cardiovascular health disparities.

Sana M. Al-Khatib, MD presents on Reducing Healthcare Disparities in Device Therapy for Patients with Heart Failure at Duke in 2014.

Resources

Beatty Moody DL, Leibel DK, Pantesco EJ, et al. Interactive relations across dimensions of interpersonal-level discrimination and depressive symptoms to carotid intimal-medial thickening in African Americans. Psychosom Med 2020; 82: 234-246.

Casey SD, Mumma BE. Sex, race, and insurance status differences in hospital treatment and outcomes following out-of-hospital cardiac arrest. Resuscitation. 2018; 126: 125‐129.

Esenwa C, Ilunga Tshiswaka D, Gebregziabher M, Ovbiagele B. Historical slavery and modern-day stroke mortality in the United States stroke belt. Stroke. 2018; 49: 465-469.

Essien UR, Holmes DN, Jackson LR 2nd, et al. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. JAMA Cardiol. 2018; 3 (12): 1174-1182.

Essien UR, Magnani JW, Chen N, Gellad WF, Fine MJ, Hernandez I. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. J Natl Med Assoc. 2020; 112 (1): 103-108.

Essien UR, Jackson LR 2nd. Race Effects in CVD Prediction Models. J Gen Intern Med. 2019; 34 (4): 484.

Fincher C, Williams JE, MacLean V, Allison JJ, Kiefe CI, Canto J. Racial disparities in coronary heart disease: a sociological view of the medical literature on physician bias. Ethn Dis. 2004; 14 (3): 360‐371.

Gauri AJ, Davis A, Hong T, et al. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med. 2006; 119: 167.e17–167.e21.

Groeneveld PW, Heidenreich PA, Garber AM. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation. 2003; 108 (3): 286‐291.

Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter‐defibrillators among patients hospitalized with heart failure. JAMA. 2007;298:1525–1532.

Ifidon AM, Agbalajobi O, Essien UR. Improving Racial and Ethnic Minority Representation in Cardiovascular Disease Trials to Advance Health Equity [published online ahead of print, 2020 Mar 4]. JAMA Cardiol. 2020; 10.1001/jamacardio.2020.0167.

Jha AK, Fisher ES, Li Z, et al. Racial trends in the use of major procedures among the elderly. N Engl J Med. 2005; 353: 683–691.

Kramer MR, Black NC, Matthews SA, James SA. Population health: the legacy of slavery and contemporary declines in heart disease mortality in the US south. SSM-Popul Health. 2017; 3: 609-617.

LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev 2000; 57: Suppl 1: 146-161.

Lukachko A, Hatzenbuehler ML, Keyes KM. Structural racism and myocardial infarction in the United States. Soc Sci Med. 2014; 103: 42‐50.

Paulus JK, Wessler BS, Lundquist CM, Kent DM. Effects of Race Are Rarely Included in Clinical Prediction Models for Cardiovascular Disease. J Gen Intern Med. 2018; 33 (9): 1429-1430.

Peterson ED, Wright SM, Daley J, et al. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA. 1994;271:1175–1180.

Sullivan LT, Randolph T, Merrill P, et al. Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction. Am Heart J. 2018; 197: 43–52.

Taylor AL. Importance of Race/Ethnicity in Clinical Trials: Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Circulation. 2005; 112 (23): 3654–3666.

Thomas KL, Al-Khatib SM, Kelsey RC 2nd, et al. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of ≤35%. Am J Cardiol. 2007; 100 (6): 924‐929.

Verma AA, Jimenez MP, Subramanian SV, et al. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circ Cardiovasc Qual Outcomes. 2017; 10 (9): e003764.

Wyatt SB, Williams DR, Calvin R, Henderson FC, Walker ER, Winters K. Racism and cardiovascular disease in African Americans. Am J Med Sci. 2003; 325 (6): 315‐331.